Fraunhofer-Chalmers Center and Captario will co-operate to develop advanced methods in AI and machine learning to take advantage of external information from a variety of data sources. The information will provide input to models and analyses in Captario SUM™ and support...
When future came knocking: Innovation in covid-19 times
Captario Announces the Release of Captario SUM™ 3.0 Beta, A Revolutionary Decision-Making Platform for Drug Development
"Svenska Saas-bolaget Captario letade nya kunder och finansiering i USA när corona-utbrottet förändrade allt. Krisen har, enligt USA-chefen Erik Post, ökat läkemedelsbolagens intresse för deras verktyg men frånvaron av personliga möten är en utmaning."
Developing drugs is risky and expensive, but you still need novel and sometimes crazy ideas to cure serious illnesses and, to stop pandemics. Swedish SaaS-startup Captario offers pharma companies a safe simulation model to help them make the right strategical decisions.
SACC New York In light of the (ongoing Coronavirus crisis and the) ramped-up race between nations and companies to develop a vaccine for COVID-19, SACCNY tapped into its vast network to hear about the latest developments in the pharmaceutical industry. We spoke with member,...
Through the initiative Rapid Scenario Evaluation (RSE), pharma companies can apply for an evaluation of a drug development project or portfolio that has been impacted by the pandemic. Based on input (e.g. via Excel) from the customer, Captario creates an end-to-end model and...
New user interface and new decision tree among the features introduced in 2019.
I would consider these books essential reading material for anyone that comes close to strategic decisions in business. Since I work in the pharmaceutical industry, I will make some comments that tie into that. However, this list applies to decision makers everywhere. 1. The...
Neil Wallace, Platform Strategy Lead at UCB, talks about the challenges in Drug Development at the Marcus Evans Conference in Barcelona 10-12 February 2020.
Captario will be attending the Marcus Evans EXECUTIVE DECISION MAKING CONFERENCE 15-18 October in Philadelphia. Come by our booth and get a personal demonstration of our decision making platform - Captario SUM.
The development of a new drug is an extremely high-risk enterprise. The attrition rates of development projects and the average costs for each launched product are daunting, and the completion of a development program requires a very long time horizon. These facts imply that...
Magnus Ytterstad of Captario in two interviews from Park Annual 2018 - one in English and one in Swedish.
Innovationsföretaget Captario har tagit in 50 miljoner kronor för att vidareutveckla sitt beslutsstödsystem SUM. Systemet åskådliggör risker och möjligheter i komplexa läkemedelsprojekt genom matematiska analyser, modeller och simuleringar.
Global pharmaceutical giants have opened their eyes to Gothenburg-based Captario and are now testing the company's product. The company therefore raises SEK 50 million to respond to the interest. The investment company Spiltan enters as the largest investor.
The innovative start-up company Captario has raised 50 million SEK to meet an increasing interest from the global pharma industry. Captario’s software makes it possible to analyze complex decisions in drug development in ways unheard of until now.
Artificial intelligence (AI) is one of the exciting ingredients in Captario’s design and decision support for drug development. Knowledge, of course, is another.
Captario is a company with a mission: to make a difference in the pharmaceutical industry through a game-changing simulation tool for decision-making in drug projects and portfolios. Founded in 2012 by a team from big pharma, Captario currently has 15 employees in offices in...
Göteborgsbolaget Captario har utvecklat ett beslutsstöd för läkemedelsindustrin. Nu skriver bolaget på för två pilotprojekt med läkemedelsjätten Novartis, med över 100 000 anställda och en omsättning på över 50 miljarder dollar.
Captario was founded in 2012, committed to making a true difference in the pharmaceutical industry. Since then Captario has built a ground-breaking technology that supports the design and decisions in drug development at both a project and portfolio level. Captario has recently...
Mikael Palmblad's, co-founder of Captario, presentation from 11 September at the life science event Park Annual 2014.
Captario co-founder Mikael Palmblad will be presenting at this year's life science innovation event. Mr Palmblad will present Captario SUM - a new software to support decision-making in drug development.
